Skip to main content
. 2015 Mar 23;24(5):600–604. doi: 10.1016/j.jsps.2015.03.021

Table 3.

Respondents’ perception on ADR reporting and pharmacovigilance.

Questions Answers (%)
P-value (% of agreement)
Strongly agree Agree Neutral Disagree Strongly disagree Gender Ethnicity
ADR reporting should be made compulsory for healthcare professionals 50.0 39.8 9.3 0.9 0.874 0.267
Information on how to report ADRs should be taught to students 65.7 30.6 2.8 0.9 0.351 0.602
With my present knowledge, I am very well prepared to report any ADRs noticeable in my future practice 3.7 26.9 56.5 11.1 1.9 0.040 0.770
Healthcare is one of the most important professions to report adverse drug reactions 65.7 25.9 3.7 3.7 0.9 0.588 0.562
Serious and unexpected reactions that are not fatal or life-threatening during clinical trials must not be reported 2.8 1.9 5.6 38.0 51.9 0.610 0.361
The purpose of ADR spontaneous reporting system is to measure the incidence of ADR 16.7 59.3 18.5 5.6 0.659 0.4268
Any ADR (serious or non-serious) should be reported spontaneously 43.5 44.4 7.4 3.7 0.9 0.421 0.003
Reason for not reporting a suspected ADR is due to the uncertainty of its association with drugs 13.9 50.9 23.1 7.4 4.6 0.038 0.804
Patients should be counselled about ADR every time their medications are dispensed 31.5 55.6 8.3 4.6 0.341 0.807
Female patients should be asked if she is pregnant when dispensing medications to them 75.0 21.3 2.8 0.9 0.437 0.012
*

P value <0.05 level of significance.